Inventor
Bore Gowda Raju
Inventor
San Diego, CA, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds51%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes14%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
PatentTitleYear
7,691,843'N-hydroxyamide derivatives possessing antibacterial activity'20106,632,829'Sulfonamides and derivatives thereof that modulate the activity of endothelin'20036,541,498'Benzenesulfonamides and the use thereof to modulate the activity of endothelin'20036,420,567'N-heteroaryl aryl-substituted thienyl-furyl-and pyrrolyl-sulfonamides and derviatives thereof that modulate the activity of endothelin'20026,376,523'Benzenesulfonamides and the use thereof to modulate the activity of endothelin'20026,342,610'N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin'20026,331,637'N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin'20016,265,428'Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin'20016,262,084'Compounds that inhibit the binding of integrins to their receptors'20016,194,448'N, N-disubstituted amides that inhibit the binding of integrins to their receptors'20016,096,773'Compounds that inhibit the binding of integrins to their receptors'20006,030,991'Benzenesulfonamides and the use thereof to modulate the activity of endothelin'20005,977,117'Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin'19995,962,490'Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin'19995,594,021'Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin'19975,591,761'Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin'19975,571,821'Sulfonamides and derivatives thereof that modulate the activity of endothelin'19965,514,691'N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin'19965,464,853'N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–1996Patents assigned to IMMUNOPHARMACEUTICS INC (2)· patent assignee history
1995–2002Based in San Diego, CA, US· patent location history
1996–2003Patents assigned to TEXAS BIOTECHNOLOGY CORP (14)· patent assignee history
1999–2002Based in Sugar Land, TX, US· patent location history
2000Patents assigned to TEXAS BIOTECHNOLOGY CORP INC (1)· patent assignee history
2000–2010Based in Fremont, CA, US· patent location history
2002–2003Based in Sugarland, TX, US· patent location history
2003Patents assigned to TEXAS BIOTECHNOLOGY (1)· patent assignee history
2010Patents assigned to PFIZER (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TEXAS BIOTECHNOLOGY CORP | 14 | 1996–2003 |
| IMMUNOPHARMACEUTICS INC | 2 | 1995–1996 |
| PFIZER | 1 | 2010 |
| TEXAS BIOTECHNOLOGY | 1 | 2003 |
| TEXAS BIOTECHNOLOGY CORP INC | 1 | 2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 9 | 1995–2002 |
| Fremont, California, US | 5 | 2000–2010 |
| Sugar Land, Texas, US | 3 | 1999–2002 |
| Sugarland, Texas, US | 2 | 2002–2003 |